NASDAQ · ASBPHealthcarePharmaceuticals

Aspire-Lakewood Holdings, Inc. Common Stock (ASBP)

$7.31+0.55%
Close Nov 4, 2026 · split-adjusted
Nov 4, 2026$7.31▼ 98.24% in range
Nov 4, 2025Low $4.65 · High $417.72Nov 4, 2026
What changed · written from our data
As of Nov 4, 2026

Aspire-Lakewood Holdings closed at $7.31 on Nov 4, up 0.55%, 98.3% below its 52-week closing high. Volume of 6.0K shares was 0.19× its 20-day average (below normal).

Split-adjusted performance: -16.6% over one month, +31.0% over six months, -98.3% over one year.

In the quarter ended Jun 30, 2026, revenue was $63.10K, with a net margin of -2009.6%.

Short interest was 8.7K shares at the Oct 15 settlement, down 36.0% from the prior report (0.9% of float, 1.0 days to cover).

Market cap$10.3M1.4M shares
Revenue · quarter$63.1K—
Diluted EPS$-1.22—
P/E · TTM—P/S 105.0×
Net margin-2,009.6%Gross 19.5%
Dividend yieldNone$0.16 last paid
52-week range4.65 – 434.04−98.3% from high
Volume6.0K0.19× 20-day avg
Volatility · 60d66.5%Annualised
Short % of float0.9%1.0 days to cover
Net cash$12.2MCash $12.2M
Next earnings—Not scheduled
Split-adjusted performance
1W −17.7%1M −16.6%3M +3.5%6M +31.0%YTD −95.4%1Y −98.3%3Y —5Y —

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Pharmaceuticals

Percentile among 420 companies (100 = best)

6-month momentum87
Revenue growth—
Net margin13
Value (low P/E)—
Size16

Industry medians: 6-month return −25.5%, revenue growth +6.2%, net margin −33.8%, P/E 16.1×.

Short interest

Details →
Shares short8.7K−36.0% vs prior
Days to cover1.0Settled Oct 15
% of float0.9%
Short vol. 10d34.1%of daily volume

Closest peers by size in Pharmaceuticals

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
ASBPAspire-Lakewood Holdings$7.31+0.55%+31.0%—−2009.6%—$10.3M
PHIOPhio Pharmaceuticals$0.8699−3.67%−24.4%———$10.1MCompare
PTNPalatin Technologies$6.02+15.33%−68.3%—−1449.1%—$10.7MCompare
BFRGBullfrog AI Holdings$0.5263+0.59%−25.4%+547.6%−636.8%—$9.8MCompare
RKTORocket One$0.4422−4.33%————$11.0MCompare
TPSTTempest Therapeutics$0.4633−1.13%−77.1%———$9.3MCompare
CALCCalciMedica$1.35−8.50%−56.8%———$9.2MCompare
LSTALisata Therapeutics$1.06−2.75%−67.5%−100.0%——$11.5MCompare
TVRDTvardi Therapeutics$0.8614+3.17%−76.5%———$11.5MCompare

News about Aspire-Lakewood Holdings

All news →

No recent articles focused on Aspire-Lakewood Holdings. 1 articles mention it in passing.

Quick answers

What does Aspire-Lakewood Holdings do?
Aspire-Lakewood Holdings Inc is a United States-based company. Along with its subsidiary, it is involved in the design and manufacture of engineered automotive and industrial control systems that combine mechanical engineering, electronics, and computer science to provide intelligent, automated systems for vehicle electrification, safety, lightweighting, and sustainability.
What is ASBP's market cap?
$10.25M, based on the Nov 4 close of $7.31.
Does Aspire-Lakewood Holdings pay a dividend?
No regular cash dividend has been paid in the last year.
How much of ASBP is sold short?
8.7K shares, 0.9% of float, as of Oct 15, 2026.
What sector is ASBP in?
Healthcare, in the Pharmaceuticals industry.

About Aspire-Lakewood Holdings

Aspire-Lakewood Holdings Inc is a United States-based company. Along with its subsidiary, it is involved in the design and manufacture of engineered automotive and industrial control systems that combine mechanical engineering, electronics, and computer science to provide intelligent, automated systems for vehicle electrification, safety, lightweighting, and sustainability. DCSC maintains a powertrain-agnostic product portfolio that includes mechatronic actuators, human-machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates around 11 manufacturing facilities globally and serves as a tier-one automotive supplier to OEMs and other industrial firms.

HQ: Estero, FLListed Feb 20, 2025aspirebiolabs.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology